<DOC>
	<DOC>NCT01179620</DOC>
	<brief_summary>This study will assess the efficacy, safety and pharmacokinetics of certoparin when used to prevent clotting during hemodialysis.</brief_summary>
	<brief_title>Certoparin in Renal Patients Undergoing Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Certoparin</mesh_term>
	<mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
	<criteria>Patients requiring hemodialysis Patients requiring anticoagulation therapy during hemodialysis Written informed consent Hypersensitivity to study medication Genetic abnormality or disease of clotting system Prior major surgery or bleeding Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Hemodialysis, Certoparin</keyword>
</DOC>